NTLA — INTELLIA THERAPEUTICS INC COM

Ownership history in Red Tortoise LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Red Tortoise LLC reported a position in INTELLIA THERAPEUTICS INC COM (NTLA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 250 — 0% 0.00% $4K $17.27
2025 Q2 ADDED 250 +109 +77.3% 0.00% $2K $9.38
2024 Q4 INITIATED 141 — — 0.00% $2K $11.66
% of Fund (quarterly)    NTLA price (monthly, adj. close)

Other funds also holding NTLA

As of 2025 Q4 — sorted by position size

REGENERON PHARMACEUTICALS, INC. 98.49% Discovery Value Fund 3Y 7Y 2.35% Birchview Capital, LP 3Y 7Y 1.66% ARK Investment Management LLC 3Y 7Y 0.85% Orchard Capital Management, LLC 3Y 0.64% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 0.45% HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 3Y 0.32% Amova Asset Management Americas, Inc. 3Y 7Y 0.23% Elmwood Wealth Management, Inc. 3Y 7Y 0.22% Headlands Technologies LLC 3Y 0.18%
← Back to Red Tortoise LLC Holdings